Evidence map›Paper›PMID 16245147›Full record

ReviewTransgenic research2005

Engineering disease resistant cattle.

David M Donovan, David E Kerr, Robert J Wall

Abstract readReview
PubMed Publisher
In one paragraph

Review in Transgenic research, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 87 citations in OpenAlex.

  1. Comparative genomic analysis ofMicrobial genomics · 2025
    Article
  2. The occurrence ofmSystems · 2024
    Article
  3. Article
  4. Review
  5. Review
  6. Comparative genomic analysis ofMicrobial genomics · 2021
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. First study of sperm mediated gene transfer in Egyptian river buffalo.Journal, genetic engineering & biotechnology · 2017
    Article
  14. Article
  15. Genome engineering in cattle: recent technological advancements.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2015
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

David M DonovanBiotechnology and Germplasm Laboratory, Agricultural Research Service, United States Department of Agriculture, Beltsville, Maryland 20705, USA.
David E Kerr
Robert J Wall
Agricultural Research Service · USUnited States Department of Agriculture · USUniversity of Vermont · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mastitis is a disease of the mammary gland caused by pathogens that find their way into the lumen of the gland through the teat canal. Mammary gland infections cost the US dairy industry approximately $2 billion dollars annually and have a similar impact in Europe. In the absence of effective treatments or breeding strategies to enhance mastitis resistance, we have created transgenic dairy cows that express lysostaphin in their mammary epithelium and secrete the antimicrobial peptide into milk. Staphylococcus aureus, a major mastitis pathogen, is exquisitely sensitive to lysostaphin. The transgenic cattle resist S. aureus mammary gland challenges, and their milk kills the bacteria, in a dose dependent manner. This first step in protecting cattle against mastitis will be followed by introduction of other genes to deal with potential resistance issues and other mastitis causing organisms. Care will be taken to avoid altering milk's nutritional and manufacturing properties. Multi-cistronic constructs may be required to achieve our goals as will other strategies possibly involving RNAi and gene targeting technology. This work demonstrates the possibility of using transgenic technology to address disease problems in agriculturally important species.

Indexed as

Genetic EngineeringAnimalsAnimals, Genetically ModifiedAntimicrobial Cationic PeptidesCattleFemaleLysostaphinMastitis, BovineMilkStaphylococcus aureusAntimicrobial Cationic PeptidesLysostaphin

Identifiers

PMID16245147
OpenAlexW1992597071

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.